Zhengye Biotechnology Holding Limited (ZYBT)
Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
1,500,000
Deal Size
$6.75M
Company Description
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.
For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs.
The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.
Zhengye Biotechnology Holding Limited
Country | China |
Founded | 2004 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 299 |
CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province China | |
Phone | +86-0432-63047008 |
Website | jlzybio.com |
Stock Details
Ticker Symbol | ZYBT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | CNY |
CIK Code | 0001975641 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Zhenfa Han | Director and Chairman of the Board |
Songlin Song | Chief Executive Officer |
Wenhua Sun | Director |
Ping Wang | Chief Financial Officer |
Zhongyao Liu | Vice General Manager |
Wei Lian | Vice General Manager |
Yawen Dong | Vice General Manager |
Yuyou He | Vice General Manager |
Wanlin Zhang | Vice General Manager |
Yuhong Cheng | Vice General Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 21, 2024 | FWP | Free Writing Prospectus |
Nov 15, 2024 | POS AM | Post-Effective amendments for registration statement |
Sep 30, 2024 | EFFECT | Notice of Effectiveness |
Sep 18, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Aug 27, 2024 | FWP | Free Writing Prospectus |
Aug 22, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jun 27, 2024 | FWP | Free Writing Prospectus |
Jun 21, 2024 | FWP | Free Writing Prospectus |
Jun 14, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jun 4, 2024 | UPLOAD | Filing |